Joseph Group Capital Management increased its stake in Invesco Pharmaceuticals ETF (NYSEARCA:PJP – Free Report) by 16.0% in the 3rd quarter, HoldingsChannel reports. The fund owned 15,080 shares of the company’s stock after acquiring an additional 2,079 shares during the period. Joseph Group Capital Management’s holdings in Invesco Pharmaceuticals ETF were worth $1,312,000 at the end of the most recent reporting period.
Other hedge funds have also made changes to their positions in the company. Envestnet Asset Management Inc. boosted its stake in Invesco Pharmaceuticals ETF by 87.7% during the 2nd quarter. Envestnet Asset Management Inc. now owns 23,878 shares of the company’s stock valued at $1,963,000 after purchasing an additional 11,156 shares in the last quarter. HBW Advisory Services LLC bought a new position in Invesco Pharmaceuticals ETF during the third quarter valued at about $509,000. &PARTNERS acquired a new position in Invesco Pharmaceuticals ETF during the second quarter worth about $308,000. Secure Asset Management LLC bought a new stake in Invesco Pharmaceuticals ETF in the third quarter worth about $229,000. Finally, Northwestern Mutual Wealth Management Co. lifted its holdings in Invesco Pharmaceuticals ETF by 49.7% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 6,826 shares of the company’s stock valued at $561,000 after acquiring an additional 2,266 shares during the last quarter.
Invesco Pharmaceuticals ETF Price Performance
PJP stock opened at $83.65 on Tuesday. The firm has a market cap of $283.57 million, a PE ratio of 21.48 and a beta of 0.61. Invesco Pharmaceuticals ETF has a 12 month low of $69.53 and a 12 month high of $89.87. The firm has a 50 day simple moving average of $87.05 and a 200 day simple moving average of $84.49.
Invesco Pharmaceuticals ETF Company Profile
PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.
Read More
- Five stocks we like better than Invesco Pharmaceuticals ETF
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- The Significance of Brokerage Rankings in Stock Selection
- Applied Materials Market Capitulates: Now is the Time to Buy
- What is a Low P/E Ratio and What Does it Tell Investors?
- 3 Ultra-High Dividend Yield Stocks for the New Year
Want to see what other hedge funds are holding PJP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invesco Pharmaceuticals ETF (NYSEARCA:PJP – Free Report).
Receive News & Ratings for Invesco Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.
